Results demonstrated that CHD5 was downregulated in tumor tissues and that low CHD5 expression was correlated with advanced TNM stage, high Fuhrman grade, lymph node metastasis, and poor survival. Here, CHD5 is linked to metastatic malignant neoplasm in the lymph nodes.